BlossomHill Therapeutics (BLSM) vs Evotec (EVO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Evotec is the larger company by market cap ($572.2 million vs $527.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLSM | EVO |
|---|---|---|
| Share price | $16.61 | $1.61 |
| Market cap | $527.95M | $572.18M |
| 1-day change | -3.93% | -1.23% |
| YTD return | — | -47.73% |
| 1-year return | — | -58.93% |
| 5-year return | — | -92.87% |
| EPS (TTM) | $-4.70 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.99 | $4.27 |
| 52-week low | $15.25 | $1.50 |
| Distance from 52-week high | -40.66% | -62.30% |
| Average volume | 263.69K | 104.15K |
| Shares outstanding | 31.78M | 355.39M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BLSM vs EVO FAQ
Which is bigger, BlossomHill Therapeutics or Evotec?
Evotec (EVO) is larger, with a market capitalization of $572.18M compared with $527.95M for BlossomHill Therapeutics (BLSM).
Are BlossomHill Therapeutics and Evotec in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.